Product Review

Criteria for Use Updates for Enzalutamide, Daratumumab, Elotuzumab, Carfilzomib, and Ixazomib

Fed Pract. 2017 May;34(suppl 3):S18-S19
PDF Download

 

Click here to read the digital edition.

Pages

Recommended Reading

Open Clinical Trials for Patients With Multiple Sclerosis (FULL)
Federal Practitioner
VA Transparency and Quality Initiatives: An Update
Federal Practitioner
NIOSH Survey: Adherence to Best Practices is Falling Short
Federal Practitioner
Singing Praises, Naming Names
Federal Practitioner
A Year 3 Progress Report on Graduate Medical Education Expansion in the Veterans Choice Act
Federal Practitioner
A Mission for Graduate Medical Education at VA
Federal Practitioner
Shulkin: Privatization Fight Led to Ouster
Federal Practitioner
Reducing the Expenditures and Workload Associated With VA Partial-Fill Prescription Processing
Federal Practitioner
Acute Exertional Upper-Extremity Rhabdomyolysis in 3 Female Trainees
Federal Practitioner
A Practical Guide to Urine Drug Monitoring
Federal Practitioner